Skip to main content

Ana Boixadera Espax

I am an ophthalmologist in the Retina section of the Ophthalmology Department. My subspecialty is Vitreoretinal Surgery and Medical Retina including Macular Surgery, Retinal Detachment surgery, Diabetic Retinopathy, Age-Related Macular Degeneration and Ocular oncology (Choroidal Tumors).

Institutions of which they are part

Ophtalmology
Vall Hebron Institut de Recerca
Doctor
Ophthalmology
General Hospital

Ana Boixadera Espax

Institutions of which they are part

Ophtalmology
Vall Hebron Institut de Recerca
Doctor
Ophthalmology
General Hospital

I am an ophthalmologist in the Retina section of the Ophthalmology Department. My subspecialty is Vitreoretinal Surgery and Medical Retina including Macular Surgery, Retinal Detachment surgery, Diabetic Retinopathy, Age-Related Macular Degeneration and Ocular oncology (Choroidal Tumors).

I did the Ophthalmology Speciality at Hospital Universitari Vall d'Hebron. Since 2003, I have been a consultant in the Retina Section, initially in charge of Age-Associated Macular Degeneration and later Diabetic Retinopathy, macular vitreoretinal surgery and Retinal Detachment surgery. I did my PhD in 2003 with the qualification of Cum Laude and got an Extraordinary Doctorate Award. I have participated in 35 publications in indexed international journals, I have made oral communications in national and international congresses of my subspecialty and I have collaborated in book chapters and therapeutic clinical guides of the Sociedad Española de Retina y Vitreo. I have collaborated in clinical trials and FIS projects that have been carried out in my Department. I have been tutor of residents since 2006 and a member of various scientific societies such as the American Academy of Ophthalmology, the Spanish Society of Retina y Vitreo, EURETINA and the Catalan Society of Ophthalmology, in which I am the treasurer at the moment.

Projects

Papel de la somatostatina-28 en la fisiopatología del edema macular secundario a uveítis

IP: José García Arumí
Collaborators: Àlex Fonollosa Calduch, Ana Boixadera Espax, Carme Macià Badia
Funding agency: Instituto de Salud Carlos III
Funding: 94985
Reference: PI070414
Duration: 01/01/2008 - 31/12/2011

Manejo de la roturas inferiores en el desprendimiento de la retina pseudofaquico. Estudio prospectivo comparativo randomizado

IP: -
Collaborators: Ana Boixadera Espax
Funding agency: Instituto de Salud Carlos III
Funding: 12650
Reference: PI040654
Duration: 01/01/2005 - 28/11/2007

Reconstrucción de la superficie ocular corneal mediante trasplante autólogo de células progenitoras del limbo cultivadas in vitro sobre membrana amniótica.

IP: Marta Torrabadella de Reynoso
Collaborators: Ana Boixadera Espax
Funding agency: Instituto de Salud Carlos III
Funding: 18400
Reference: PI020800
Duration: 06/11/2002 - 06/05/2006

Related news

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Dr. José García Arumi and Dr. Anna Duarri from the Ophthalmology research group at Vall Hebron Recerca lead the project. 

Related professionals

Anna Salas  Martinez

Anna Salas Martinez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Ernesto Melchor Guerra Farfan

Ernesto Melchor Guerra Farfan

Reconstructive Surgery of the Locomotor System
Read more
Adrià  Tomé Cabello

Adrià Tomé Cabello

Medium Grade Technician
IT / Information Systems
Digital Transformation Directorate
Read more
Sara Delgado Tomás

Sara Delgado Tomás

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.